Cargando…
Translation of Anticancer Efficacy From Nonclinical Models to the Clinic
Mouse cancer models have provided critical insights into tumor biology; however, clinical translation of these findings has been challenging. This perspective posits that factors impacting on successful translation start with limitations in capturing human cancer pathophysiology and end with challen...
Autores principales: | Stroh, M, Duda, D G, Takimoto, C H, Yamazaki, S, Vicini, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150926/ https://www.ncbi.nlm.nih.gov/pubmed/25098530 http://dx.doi.org/10.1038/psp.2014.28 |
Ejemplares similares
-
Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development
por: Visser, S A G, et al.
Publicado: (2013) -
Zika vaccine candidates progress through nonclinical development and enter clinical trials
por: Barrett, Alan D T
Publicado: (2016) -
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
por: Bulitta, Jürgen B., et al.
Publicado: (2019) -
PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development
por: Oggianu, Laura, et al.
Publicado: (2023) -
Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
por: Vicini, Paolo, et al.
Publicado: (2019)